A comprehensive review on azole-based hydroxamic acid analogs as histone deacetylases (HDACs) inhibitors
ABHA hybrids provide versatile scaffolds with diverse activity for the rational development of next-generation, isoform-selective HDACIs with enhanced potency and therapeutic promise in anticancer drug design.
Authors
- Anjali Murmu (ORCID: https://orcid.org/0000-0001-8783-4275)
- Pragya Gawande (ORCID: https://orcid.org/0009-0006-0707-0396)
- Jagadish Singh
- Deepali Shukla
- Partha Pratim Roy
- Balaji Wamanrao Matore
Institutions
- Guru Ghasidas Vishwavidyalaya (IN)
Publication Details
- Journal
- Future Medicinal Chemistry
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1080/17568919.2025.2605010
- Primary Topic
- Histone Deacetylase Inhibitors Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00